Antonio Montemurro, DPM
Primary Podiatric Medicine · Pleasant Prairie, WINPI 1700126562
Payments from drug & device makers
Across 65 payments — averaging $70.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Trilliant Surgical LLC.$3K
- Stryker$308
- Medshape, Inc.$290
- Celularity Inc.$191
- Smith+Nephew$132
- Anika Therapeutics, Inc.$57
- plus $437 from 19 others
What the payments were for
- Royalty or licence$2,03645%
- Travel & lodging$1,15125%
- Food & beverage$1,37030%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Trilliant Surgical LLC. | 14 | $3,142 |
| Stryker(2 entities) | 10 | $308 |
| Medshape, Inc. | 3 | $290 |
| Celularity Inc. | 3 | $191 |
| Smith+Nephew | 6 | $132 |
| Anika Therapeutics, Inc. | 2 | $57 |
| Johnson & Johnson | 3 | $51 |
| Fusion Orthopedics USA, LLC | 2 | $42 |
| Encore Medical, LP | 2 | $41 |
| Arthrosurface Incorporated | 2 | $36 |
| In2bones USA, LLC | 2 | $36 |
| Medline Industries LP | 2 | $32 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $25 |
| IBSA Pharma Inc. | 1 | $20 |
| Treace Medical Concepts, Inc. | 1 | $17 |
| AbbVie | 1 | $16 |
| Nevro Corp. | 1 | $16 |
| Amgen | 1 | $16 |
| Zimvie Inc. | 1 | $15 |
| Averitas Pharma Inc. | 1 | $14 |
| KCI USA, Inc. | 1 | $13 |
| Orthofix Medical, Inc. | 1 | $13 |
| Zimmer Biomet | 1 | $13 |
| Merck | 1 | $12 |
| Electronic Waveform Lab, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few primary podiatric medicine providers in Wisconsinto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JubliaEfinaconazole | 16 | $12,115 |
| Linezolid | 14 | $1,969 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 31 | $897 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 69 | $519 |
| Duloxetine Hcl | 20 | $493 |
| Ciclopirox | 14 | $490 |
| Imiquimod | 14 | $470 |
| Diclofenac Sodium | 20 | $431 |
| Terbinafine Hcl | 25 | $365 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 39 | $314 |
| Cephalexin | 32 | $243 |
| Celecoxib | 21 | $220 |
| Meloxicam | 66 | $183 |
| Ciprofloxacin Hcl | 13 | $135 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $104 |
Paid to pharmacies, not to this prescriber.
Other primary podiatric medicine in Pleasant Prairie
- Magali Fournierla Crosse$11K
- Timothy TougasAppleton$567
- Heather ChestelsonViroqua$251
- Stephen BogueMadison$113
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.